BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33622391)

  • 1. DNA methylation of blood cells is associated with prevalent type 2 diabetes in a meta-analysis of four European cohorts.
    Juvinao-Quintero DL; Marioni RE; Ochoa-Rosales C; Russ TC; Deary IJ; van Meurs JBJ; Voortman T; Hivert MF; Sharp GC; Relton CL; Elliott HR
    Clin Epigenetics; 2021 Feb; 13(1):40. PubMed ID: 33622391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-wide association study in whole blood on type 2 diabetes among sub-Saharan African individuals: findings from the RODAM study.
    Meeks KAC; Henneman P; Venema A; Addo J; Bahendeka S; Burr T; Danquah I; Galbete C; Mannens MMAM; Mockenhaupt FP; Owusu-Dabo E; Rotimi CN; Schulze MB; Smeeth L; Spranger J; Zafarmand MH; Adeyemo A; Agyemang C
    Int J Epidemiol; 2019 Feb; 48(1):58-70. PubMed ID: 30107520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    Hillary RF; McCartney DL; Smith HM; Bernabeu E; Gadd DA; Chybowska AD; Cheng Y; Murphy L; Wrobel N; Campbell A; Walker RM; Hayward C; Evans KL; McIntosh AM; Marioni RE
    PLoS Med; 2023 Jul; 20(7):e1004247. PubMed ID: 37410739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
    Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood DNA methylation signature of diet quality and association with cardiometabolic traits.
    Domínguez-Barragán J; Fernández-Sanlés A; Hernáez Á; Llauradó-Pont J; Marrugat J; Robinson O; Tzoulaki I; Elosua R; Lassale C
    Eur J Prev Cardiol; 2024 Jan; 31(2):191-202. PubMed ID: 37793095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic associations of type 2 diabetes and BMI in an Arab population.
    Al Muftah WA; Al-Shafai M; Zaghlool SB; Visconti A; Tsai PC; Kumar P; Spector T; Bell J; Falchi M; Suhre K
    Clin Epigenetics; 2016; 8():13. PubMed ID: 26823690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of epigenome-wide DNA methylation reveals novel loci associated with BMI change in East Asians.
    Li W; Xia M; Zeng H; Lin H; Teschendorff AE; Gao X; Wang S
    Clin Epigenetics; 2024 May; 16(1):70. PubMed ID: 38802969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome- and epigenome-wide association studies identify susceptibility of CpG sites and regions for metabolic syndrome in a Korean population.
    Lee HS; Kim B; Park T
    Clin Epigenetics; 2024 Apr; 16(1):60. PubMed ID: 38685121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study.
    Braun KVE; Dhana K; de Vries PS; Voortman T; van Meurs JBJ; Uitterlinden AG; ; Hofman A; Hu FB; Franco OH; Dehghan A
    Clin Epigenetics; 2017; 9():15. PubMed ID: 28194238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient's classifications.
    Giri AK; Prasad G; Parekatt V; Rajashekar D; Tandon N; Bharadwaj D
    Hum Mol Genet; 2023 Aug; 32(16):2576-2586. PubMed ID: 37184252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.
    Florath I; Butterbach K; Heiss J; Bewerunge-Hudler M; Zhang Y; Schöttker B; Brenner H
    Diabetologia; 2016 Jan; 59(1):130-138. PubMed ID: 26433941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families.
    Mamtani M; Kulkarni H; Dyer TD; Göring HH; Neary JL; Cole SA; Kent JW; Kumar S; Glahn DC; Mahaney MC; Comuzzie AG; Almasy L; Curran JE; Duggirala R; Blangero J; Carless MA
    Clin Epigenetics; 2016; 8():6. PubMed ID: 26798409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.
    Sayols-Baixeras S; Subirana I; Lluis-Ganella C; Civeira F; Roquer J; Do AN; Absher D; Cenarro A; Muñoz D; Soriano-Tárraga C; Jiménez-Conde J; Ordovas JM; Senti M; Aslibekyan S; Marrugat J; Arnett DK; Elosua R
    Hum Mol Genet; 2016 Oct; 25(20):4556-4565. PubMed ID: 28173150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA
    Walaszczyk E; Luijten M; Spijkerman AMW; Bonder MJ; Lutgers HL; Snieder H; Wolffenbuttel BHR; van Vliet-Ostaptchouk JV
    Diabetologia; 2018 Feb; 61(2):354-368. PubMed ID: 29164275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation changes in the peripheral blood of Filipinos with type 2 diabetes suggest spurious transcription initiation at TXNIP.
    Albao DS; Cutiongco-de la Paz EM; Mercado ME; Lirio A; Mariano M; Kim S; Yangco A; Melegrito J; Wad-Asen K; Gauran II; Francisco MA; Santos-Acuin C; David-Padilla C; Murphy EJ; Paz-Pacheco E; Seielstad M
    Hum Mol Genet; 2019 Dec; 28(24):4208-4218. PubMed ID: 31691802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study.
    Chambers JC; Loh M; Lehne B; Drong A; Kriebel J; Motta V; Wahl S; Elliott HR; Rota F; Scott WR; Zhang W; Tan ST; Campanella G; Chadeau-Hyam M; Yengo L; Richmond RC; Adamowicz-Brice M; Afzal U; Bozaoglu K; Mok ZY; Ng HK; Pattou F; Prokisch H; Rozario MA; Tarantini L; Abbott J; Ala-Korpela M; Albetti B; Ammerpohl O; Bertazzi PA; Blancher C; Caiazzo R; Danesh J; Gaunt TR; de Lusignan S; Gieger C; Illig T; Jha S; Jones S; Jowett J; Kangas AJ; Kasturiratne A; Kato N; Kotea N; Kowlessur S; Pitkäniemi J; Punjabi P; Saleheen D; Schafmayer C; Soininen P; Tai ES; Thorand B; Tuomilehto J; Wickremasinghe AR; Kyrtopoulos SA; Aitman TJ; Herder C; Hampe J; Cauchi S; Relton CL; Froguel P; Soong R; Vineis P; Jarvelin MR; Scott J; Grallert H; Bollati V; Elliott P; McCarthy MI; Kooner JS
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):526-534. PubMed ID: 26095709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population.
    Kim H; Bae JH; Park KS; Sung J; Kwak SH
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3837-e3851. PubMed ID: 34214161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel epigenetic determinants of type 2 diabetes in Mexican-American families.
    Kulkarni H; Kos MZ; Neary J; Dyer TD; Kent JW; Göring HH; Cole SA; Comuzzie AG; Almasy L; Mahaney MC; Curran JE; Blangero J; Carless MA
    Hum Mol Genet; 2015 Sep; 24(18):5330-44. PubMed ID: 26101197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated epigenome, whole genome sequence and metabolome analyses identify novel multi-omics pathways in type 2 diabetes: a Middle Eastern study.
    Yousri NA; Albagha OME; Hunt SC
    BMC Med; 2023 Sep; 21(1):347. PubMed ID: 37679740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control meta-analysis of blood DNA methylation and autism spectrum disorder.
    Andrews SV; Sheppard B; Windham GC; Schieve LA; Schendel DE; Croen LA; Chopra P; Alisch RS; Newschaffer CJ; Warren ST; Feinberg AP; Fallin MD; Ladd-Acosta C
    Mol Autism; 2018; 9():40. PubMed ID: 29988321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.